RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
U-Neuron Biomedical Stock

U-Neuron Biomedical ROA 2024

U-Neuron Biomedical ROA

-0.16

Ticker

6973.TWO

ISIN

TW0006973001

In 2024, U-Neuron Biomedical's return on assets (ROA) was -0.16, a -29.98% increase from the -0.23 ROA in the previous year.

U-Neuron Biomedical Aktienanalyse

What does U-Neuron Biomedical do?

U-Neuron Biomedical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding U-Neuron Biomedical's Return on Assets (ROA)

U-Neuron Biomedical's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing U-Neuron Biomedical's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider U-Neuron Biomedical's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in U-Neuron Biomedical’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about U-Neuron Biomedical stock

What is the Return on Assets (ROA) of U-Neuron Biomedical this year?

The Return on Assets (ROA) of U-Neuron Biomedical is -0.16 undefined this year.

What was the ROA of U-Neuron Biomedical compared to the previous year?

The ROA of U-Neuron Biomedical has increased by -29.98% compared to the previous year.

What consequences do high ROA have for investors of U-Neuron Biomedical?

A high ROA is advantageous for investors of U-Neuron Biomedical, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in U-Neuron Biomedical?

A low ROA can be unfavorable for investors of U-Neuron Biomedical as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of U-Neuron Biomedical affect the company?

An increase in ROA of U-Neuron Biomedical can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of U-Neuron Biomedical impact the company?

A reduction in the ROA of U-Neuron Biomedical can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of U-Neuron Biomedical?

Some factors that can influence the ROA of U-Neuron Biomedical include revenue, operating costs, asset structure, and industry average.

Why is the ROA of U-Neuron Biomedical important for investors?

The ROA of U-Neuron Biomedical is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can U-Neuron Biomedical take to improve ROA?

To improve ROA, U-Neuron Biomedical can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does U-Neuron Biomedical pay?

Over the past 12 months, U-Neuron Biomedical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, U-Neuron Biomedical is expected to pay a dividend of 0 TWD.

What is the dividend yield of U-Neuron Biomedical?

The current dividend yield of U-Neuron Biomedical is .

When does U-Neuron Biomedical pay dividends?

U-Neuron Biomedical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of U-Neuron Biomedical?

U-Neuron Biomedical paid dividends every year for the past 0 years.

What is the dividend of U-Neuron Biomedical?

For the upcoming 12 months, dividends amounting to 0 TWD are expected. This corresponds to a dividend yield of 0 %.

In which sector is U-Neuron Biomedical located?

U-Neuron Biomedical is assigned to the 'Health' sector.

Wann musste ich die Aktien von U-Neuron Biomedical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of U-Neuron Biomedical from 12/5/2024 amounting to 0 TWD, you needed to have the stock in your portfolio before the ex-date on 12/5/2024.

When did U-Neuron Biomedical pay the last dividend?

The last dividend was paid out on 12/5/2024.

What was the dividend of U-Neuron Biomedical in the year 2023?

In the year 2023, U-Neuron Biomedical distributed 0 TWD as dividends.

In which currency does U-Neuron Biomedical pay out the dividend?

The dividends of U-Neuron Biomedical are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von U-Neuron Biomedical

Our stock analysis for U-Neuron Biomedical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of U-Neuron Biomedical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.